Time
Days to earnings13
Next print2026-10-29
WindowAMC
Fiscal2026-09-30
NASDAQ · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
GILD
Gilead Sciences Inc primary
150.43
Full stocks workspace →-0.74-0.5%
Street
Consensus EPS2.164
Consensus revenue7.8B
EPS high / low2.68 / 1.904 · 35.8% · n=22
Rev / avg0 / — · 2.148 / 2.144
Options
IV front26.9%
Implied move5.8%
Put/call full0.56
Put/call front0.58
Short interest
Short shares21.8M / 18.3M · +19.25%
Days to cover3.36
Avg vol · float6.5M · 1.2B
Short % float1.76%
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 13 | 2026-10-29 | 150.43 | 2.164 | 26.9% | 5.8% | +4.0% | -1.2% | +2.7% | +3.3% | 2.68 / 1.904 | 35.8% | 22 | 0.56 | 0 | |
| 2026-10-09 | 14 | 2026-10-29 | 151.17 | 2.148 | 33.2% | 7.8% | +4.4% | +0.2% | +5.2% | +1.6% | 2.68 / 1.904 | 36.1% | 22 | 0.56 | 0 | |
| 2026-10-08 | 15 | 2026-10-29 | 147.10 | 2.148 | 27.8% | 6.7% | -0.3% | -1.7% | +1.6% | -0.7% | 2.68 / 1.904 | 36.1% | 22 | 0.56 | 0 | |
| 2026-10-07 | 16 | 2026-10-29 | 146.85 | 2.148 | 27.3% | 6.7% | -1.5% | -3.0% | +0.8% | -1.3% | 2.68 / 1.904 | 36.1% | 22 | 0.56 | 0 | |
| 2026-10-06 | 17 | 2026-10-29 | 144.23 | 2.148 | 27.8% | 7.0% | -4.7% | -5.5% | -1.6% | -1.7% | 2.68 / 1.904 | 36.1% | 22 | 0.57 | 0 | |
| 2026-10-05 | 18 | 2026-10-29 | 144.63 | 2.148 | 28.8% | 7.4% | -5.0% | -3.9% | -4.2% | -1.0% | 2.68 / 1.904 | 36.1% | 22 | 0.57 | 0 | |
| 2026-10-02 | 19 | 2026-10-29 | 144.74 | 2.148 | 28.3% | 7.7% | -4.1% | -3.6% | -4.3% | +0.9% | 2.68 / 1.904 | 36.1% | 22 | 0.56 | 0 | |
| 2026-10-01 | 20 | 2026-10-29 | 147.50 | 2.148 | 30.3% | 8.4% | -1.5% | -2.2% | -1.4% | -0.1% | 2.68 / 1.904 | 36.1% | 22 | 0.51 | 0 | |
| 2026-09-30 | 21 | 2026-10-29 | 149.05 | 2.148 | 29.3% | 8.3% | -1.5% | +0.9% | -0.6% | +3.9% | 2.68 / 1.904 | 36.1% | 22 | 0.51 | 0 | |
| 2026-09-29 | 22 | 2026-10-29 | 151.28 | 2.148 | 29.3% | 8.4% | -0.9% | +3.4% | +3.4% | +8.9% | 2.68 / 1.904 | 36.1% | 22 | 0.51 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| AMGN primary | Amgen Inc | 0.47 | 2026Q2 · 2026-08-04 | +12.3% | +0.9% | 407.83 | 16 · 2026-10-12 |
| VRTX primary | Vertex Pharmaceuticals Inc | 0.45 | 2026Q2 · 2026-08-03 | +1.2% | +0.1% | 478.71 | 15 · 2026-10-12 |
| REGN primary | Regeneron Pharmaceuticals Inc | 0.32 | 2026Q2 · 2026-07-30 | +56.6% | +0.9% | 738.34 | 14 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-08-03 | AMC | -6.75 | +4.5% | Beat | 0.0% | +3.1% | 1.54× | +6.1% | Review |
| 2026Q1 | 2026-05-07 | AMC | 2.03 | +6.3% | Beat | -3.0% | +1.0% | 1.59× | +2.3% | Review |
| 2025Q4 | 2026-02-10 | AMC | 1.86 | +2.8% | Beat | +1.1% | +4.6% | 1.41× | -7.7% | Review |
| 2025Q3 | 2025-10-30 | AMC | 2.47 | +15.4% | Beat | -2.0% | +3.2% | 1.46× | +4.4% | Review |
| 2025Q2 | 2025-08-07 | AMC | 2.01 | +3.1% | Beat | +4.5% | +3.6% | 1.97× | -3.9% | Review |
| 2025Q1 | 2025-04-24 | AMC | 1.81 | +1.7% | Beat | -3.3% | +0.5% | 1.68× | -6.1% | Review |
| 2024Q4 | 2025-02-11 | AMC | 1.90 | +11.7% | Beat | +5.8% | +1.5% | 2.25× | +8.4% | Review |
| 2024Q3 | 2024-11-06 | AMC | 2.02 | +30.3% | Beat | +2.5% | +4.1% | 2.30× | -8.3% | Review |
| 2024Q2 | 2024-08-08 | AMC | 2.01 | +25.6% | Beat | -0.9% | -1.7% | 1.54× | +4.2% | Review |
| 2024Q1 | 2024-04-25 | AMC | -1.32 | +13.2% | Beat | +0.4% | -0.1% | 1.64× | +0.8% | Review |